Medicago: Perennial proteins By Kathryn Calkins
Staff Writer

Production of recombinant proteins in plants runs up against skepticism in terms of the ability of plant factories to reproducibly manufacture commercial quantities of peptide. In addition, fears of public animosity toward genetically modified agriculture could bode ill for acceptance of the technology on a broad scale, especially in Europe.